Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

cardinal health 107, llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings ). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings ). the routes of administration and indicated bupivacaine hydrochloride concentrations are: •local infiltration 0.25% •peripheral nerve block 0.25% and 0.5% •retrobulbar block 0.75% •sympathetic block 0.25% •lumbar epidural 0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) •caudal 0.25% and 0.5% •epidural test dose 0.5% with epinephrine 1:200,000 •dental blocks 0.5% with epinephrine 1:200,000 (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique has resulted in fetal bradycardia and death. bupivacaine hydrochloride is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride solutions.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

medical purchasing solutions, llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings ). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings ). the routes of administration and indicated bupivacaine hydrochloride concentrations are: •local infiltration 0.25% •peripheral nerve block 0.25% and 0.5% •retrobulbar block 0.75% •sympathetic block 0.25% •lumbar epidural 0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) •caudal 0.25% and 0.5% •epidural test dose 0.5% with epinephrine 1:200,000 •d

Irska - engleski - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - bupivacaine hydrochloride - solution for injection - 0.25 percent weight/volume - amides; bupivacaine

Irska - engleski - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - bupivacaine hydrochloride - solution for injection - 0.5 percent weight/volume - amides; bupivacaine

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 2.5 mg/ml - solution for injection - 0.25 % - active: bupivacaine hydrochloride monohydrate 2.5 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - surgical anaesthesia - epidural block for surgery

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 5 mg/ml - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 5 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - surgical anaesthesia - epidural block for surgery

Irska - engleski - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - bupivacaine hydrochloride, monohydrate - solution for injection - 2.5 mg/ml

Irska - engleski - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - bupivacaine hydrochloride, monohydrate - solution for injection - 5 mg/ml

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

septodont inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride 5 mg in 1 ml - vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is not recommended for children. vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of vivacaine™ (bupivacaine hydrochloride and epinephrine injection, usp) solutions.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - bupivacaine hydrochloride monohydrate 5.28 mg/ml equivalent to bupivacaine hydrochloride 5mg/ml - solution for injection - 0.5% w/v - active: bupivacaine hydrochloride monohydrate 5.28 mg/ml equivalent to bupivacaine hydrochloride 5mg/ml excipient: glucose monohydrate sodium hydroxide water for injection - bupivacaine spinal heavy bnm is indicated for · intrathecal (subarachnoid, spinal) anaesthesia for surgical and obstetrical procedures · lower abdominal surgery (including caesarean section), urological and lower limb, including hip surgery, lasting 1.5 to 3 hours.